BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Daly JM, Fry WA, Little AG, Winchester DP, McKee RF, Stewart AK, Fremgen AM. Esophageal cancer: results of an American College of Surgeons Patient Care Evaluation Study. J Am Coll Surg. 2000;190:562-572; discussion 572-573. [PMID: 10801023 DOI: 10.1016/s1072-7515(00)00238-6] [Cited by in Crossref: 310] [Cited by in F6Publishing: 149] [Article Influence: 14.1] [Reference Citation Analysis]
Number Citing Articles
1 Chen X, Yan CC, Zhang X, You ZH, Huang YA, Yan GY. HGIMDA: Heterogeneous graph inference for miRNA-disease association prediction. Oncotarget 2016;7:65257-69. [PMID: 27533456 DOI: 10.18632/oncotarget.11251] [Cited by in Crossref: 156] [Cited by in F6Publishing: 136] [Article Influence: 39.0] [Reference Citation Analysis]
2 Ye J, Zhang L, Li Z, Lin R, Song Y, Ni H, Gou X, Xie R. High Expression of MDM2 and the p53 Protein is Predictive Biomarkers for Poor Prognosis of Oesophageal Squamous Cell Carcinoma. Cancer Manag Res 2021;13:2733-44. [PMID: 33790647 DOI: 10.2147/CMAR.S280326] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Tuynman JB, Buskens CJ, Kemper K, ten Kate FJ, Offerhaus GJ, Richel DJ, van Lanschot JJ. Neoadj-uvant selective COX-2 inhibition down-regulates important oncogenic pathways in patients with esophageal adenocarcinoma. Ann Surg. 2005;242:840-849. [PMID: 16327494 DOI: 10.1097/01.sla.0000189546.77520.ef] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
4 Yang H, Gu J, Wang KK, Zhang W, Xing J, Chen Z, Ajani JA, Wu X. MicroRNA expression signatures in Barrett's esophagus and esophageal adenocarcinoma. Clin Cancer Res. 2009;15:5744-5752. [PMID: 19737949 DOI: 10.1158/1078-0432.ccr-09-0385] [Cited by in Crossref: 91] [Cited by in F6Publishing: 62] [Article Influence: 7.0] [Reference Citation Analysis]
5 Esenwein SA, Martin D, Kuhnen C, Reimer R, Muhr G. [Retrogastral located gastrointestinal stromal tumor (GIST) as a sonographically detected rare incidental finding]. Zentralbl Chir. 2002;127:322-325. [PMID: 16843872 DOI: 10.1055/s-2002-31561] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
6 Guo W, Jiang YG. Current gene expression studies in esophageal carcinoma. Curr Genomics 2009;10:534-9. [PMID: 20514215 DOI: 10.2174/138920209789503888] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
7 Zhou X, Qiu GQ, Bao WA, Zhang DH. The prognostic role of nutrition risk score (NRS) in patients with metastatic or recurrent esophageal squamous cell carcinoma (ESCC). Oncotarget 2017;8:77465-73. [PMID: 29100401 DOI: 10.18632/oncotarget.20530] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Law S, Kwong DL, Wong KH, Kwok KF, Wong J. The effects of neoadjuvant chemoradiation on pTNM staging and its prognostic significance in esophageal cancer. J Gastrointest Surg 2006;10:1301-11. [PMID: 17114016 DOI: 10.1016/j.gassur.2006.06.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
9 Wudel LJ Jr, Chapman WC. Indications and limitations of liver transplantation for hepatocellular carcinoma. Surg Oncol Clin N Am. 2003;12:77-90, ix. [PMID: 16843872 DOI: 10.1016/S1055-3207(02)00092-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
10 Kumaran D, John S, Isiah R, Das S. Management of Locally Advanced Carcinoma Oesophagus with Radiation/Chemoradiation: Single Institute Experience. J Gastrointest Cancer 2016;47:313-7. [PMID: 27146042 DOI: 10.1007/s12029-016-9825-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
11 Wang Y, Wang Q, Zhang N, Ma H, Gu Y, Tang H, Xu Z, Gao Y. Identification of microRNAs as novel biomarkers for detecting esophageal squamous cell carcinoma in Asians: a meta-analysis. Tumour Biol. 2014;35:11595-11604. [PMID: 25135426 DOI: 10.1007/s13277-014-2350-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
12 Amorim CA, De Souza LP, Moreira JP, Luiz RR, De V Carneiro AJ, De Souza HSP. Geographic distribution and time trends of esophageal cancer in Brazil from 2005 to 2015. Mol Clin Oncol 2019;10:631-8. [PMID: 31086670 DOI: 10.3892/mco.2019.1842] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
13 Sharma P, Gautam SD, Rajendra S. Importance of investigating high-risk human papillomavirus in lymph node metastasis of esophageal adenocarcinoma. World J Gastroenterol 2020; 26(21): 2729-2739 [PMID: 32550750 DOI: 10.3748/wjg.v26.i21.2729] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Ellis R, Cole AJ, O'Hare J, Whitten G, Crowther K, Harrison C. Coincidental splenic irradiation and risk of functional hyposplenism in oesophageal cancer treatment. J Med Imaging Radiat Oncol 2021. [PMID: 34405578 DOI: 10.1111/1754-9485.13310] [Reference Citation Analysis]
15 Ishikawa K, Komuro T, Hirota S, Kitamura Y. Ultrastructural identification of the c-kit-expressing interstitial cells in the rat stomach: a comparison of control and Ws/Ws mutant rats. Cell Tissue Res. 1997;289:137-143. [PMID: 16843872 DOI: 10.1007/s004410050859] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 3.0] [Reference Citation Analysis]
16 Gómez Senent S, Gómez Raposo C, Segura Cabral JM. Cáncer de esófago. Medicina Clínica 2008;130:423-8. [DOI: 10.1157/13117853] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Song PI, Liang H, Fan JH, Wei WQ, Wang GQ, Qiao YL. Long-term survival after esophagectomy for early esophageal squamous cell carcinoma in Linxian, China. J Surg Oncol 2011;104:176-80. [PMID: 21538356 DOI: 10.1002/jso.21953] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
18 Tan MC, Mansour N, White DL, Sisson A, El-Serag HB, Thrift AP. Systematic review with meta-analysis: prevalence of prior and concurrent Barrett's oesophagus in oesophageal adenocarcinoma patients. Aliment Pharmacol Ther 2020;52:20-36. [PMID: 32452599 DOI: 10.1111/apt.15760] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
19 Castera L, Foucher J, Bertet J, Couzigou P, de Ledinghen V. FibroScan and FibroTest to assess liver fibrosis in HCV with normal aminotransferases. Hepatology. 2006;43:373-374; author reply 375-376. [PMID: 16843872 DOI: 10.1002/hep.21019] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 2.4] [Reference Citation Analysis]
20 Anandavadivelan P, Lagergren P. Cachexia in patients with oesophageal cancer. Nat Rev Clin Oncol 2016;13:185-98. [PMID: 26573424 DOI: 10.1038/nrclinonc.2015.200] [Cited by in Crossref: 77] [Cited by in F6Publishing: 72] [Article Influence: 11.0] [Reference Citation Analysis]
21 Genc B, Kantarci M, Sade R, Orsal E, Ogul H, Okur A, Aydin Y, Karaca L, Eroğlu A. The Comparison of Computed Tomography Perfusion, Contrast-Enhanced Computed Tomography and Positron-Emission Tomography/Computed Tomography for the Detection of Primary Esophageal Carcinoma. Med Princ Pract 2016;25:254-9. [PMID: 26784024 DOI: 10.1159/000444086] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Guan NN, Wang CC, Zhang L, Huang L, Li JQ, Piao X. In silico prediction of potential miRNA-disease association using an integrative bioinformatics approach based on kernel fusion. J Cell Mol Med 2020;24:573-87. [PMID: 31747722 DOI: 10.1111/jcmm.14765] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
23 Ran J, Li H, Li H. System Review about Function Role of ESCC Driver Gene KDM6A by Network Biology Approach. ScientificWorldJournal 2016;2016:1970904. [PMID: 27294188 DOI: 10.1155/2016/1970904] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
24 Gu WS, Fang WZ, Liu CY, Pan KY, Ding R, Li XH, Duan CH. Prognostic significance of combined pretreatment body mass index (BMI) and BMI loss in patients with esophageal cancer. Cancer Manag Res 2019;11:3029-41. [PMID: 31114349 DOI: 10.2147/CMAR.S197820] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
25 Kosuga T, Shiozaki A, Fujiwara H, Ichikawa D, Okamoto K, Komatsu S, Otsuji E. Treatment outcome and prognosis of patients with lymph node recurrence of thoracic esophageal squamous cell carcinoma after curative resection. World J Surg 2011;35:798-804. [PMID: 21312037 DOI: 10.1007/s00268-011-0978-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
26 Zikri NN, Riedl KM, Wang LS, Lechner J, Schwartz SJ, Stoner GD. Black raspberry components inhibit proliferation, induce apoptosis, and modulate gene expression in rat esophageal epithelial cells. Nutr Cancer. 2009;61:816-826. [PMID: 20155622 DOI: 10.1080/01635580903285148] [Cited by in Crossref: 64] [Cited by in F6Publishing: 46] [Article Influence: 5.3] [Reference Citation Analysis]
27 Taniyama Y, Sakurai T, Heishi T, Okamoto H, Sato C, Maruyama S, Onodera Y, Ishida H, Unno M, Kamei T. Different strategy of salvage esophagectomy between residual and recurrent esophageal cancer after definitive chemoradiotherapy. J Thorac Dis 2018;10:1554-62. [PMID: 29707306 DOI: 10.21037/jtd.2018.03.04] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
28 Arrington AK, Davydova J, Vickers SM, Yamamoto M. Anti-ERBB2 sh-RNA suppress both cell growth and tumor growth in ERBB2-overexpressing upper gastrointestinal adenocarcinomas. J Gastrointest Surg 2009;13:1754-61. [PMID: 19813066 DOI: 10.1007/s11605-009-0957-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
29 Zhao Q, Shen JH, Shen ZY, Wu ZY, Xu XE, Xie JJ, Wu JY, Huang Q, Lu XF, Li EM, Xu LY. Phosphorylation of fascin decreases the risk of poor survival in patients with esophageal squamous cell carcinoma. J Histochem Cytochem 2010;58:979-88. [PMID: 20713986 DOI: 10.1369/jhc.2010.955765] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
30 Cowan KJ, Storey KB. Mitogen-activated protein kinases: new signaling pathways functioning in cellular responses to environmental stress. J Exp Biol. 2003;206:1107-1115. [PMID: 16843872 DOI: 10.1242/jeb.00220] [Cited by in Crossref: 389] [Cited by in F6Publishing: 393] [Article Influence: 24.3] [Reference Citation Analysis]
31 Ding X, Zhang J, Li B, Wang Z, Huang W, Zhou T, Wei Y, Li H. A meta-analysis of lymph node metastasis rate for patients with thoracic oesophageal cancer and its implication in delineation of clinical target volume for radiation therapy. Br J Radiol 2012;85:e1110-9. [PMID: 22700258 DOI: 10.1259/bjr/12500248] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
32 Chen F, Luo H, Xing L, Liang N, Xie J, Zhang J. Feasibility and efficiency of concurrent chemoradiotherapy with capecitabine and cisplatin versus radiotherapy alone for elderly patients with locally advanced esophageal squamous cell carcinoma: Experience of two centers. Thorac Cancer 2018;9:59-65. [PMID: 29024498 DOI: 10.1111/1759-7714.12536] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
33 Mimatsu K, Fukino N, Ogasawara Y, Saino Y, Oida T. Effects of Enteral Immunonutrition in Esophageal Cancer. Gastrointest Tumors 2018;4:61-71. [PMID: 29594107 DOI: 10.1159/000481797] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
34 Choy B, Bandla S, Xia Y, Tan D, Pennathur A, Luketich JD, Godfrey TE, Peters JH, Sun J, Zhou Z. Clinicopathologic characteristics of high expression of Bmi-1 in esophageal adenocarcinoma and squamous cell carcinoma. BMC Gastroenterol. 2012;12:146. [PMID: 23078618 DOI: 10.1186/1471-230x-12-146] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
35 Takei Y, Okumura S, Nagal H. TNF-α induced apoptosis of hepatocyte precedes massive hepatic necrosis during the cause of acute hepatitis failure. Hepatology. 1995;22:380-390. [PMID: 16843872 DOI: 10.1016/0270-9139(95)95240-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Järvinen T, Ilonen I, Kauppi J, Salo J, Räsänen J. Loss of skeletal muscle mass during neoadjuvant treatments correlates with worse prognosis in esophageal cancer: a retrospective cohort study. World J Surg Oncol 2018;16:27. [PMID: 29433514 DOI: 10.1186/s12957-018-1327-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 7.3] [Reference Citation Analysis]
37 Liang Y, Mao Q, Wang L, Xia W, Chen B, Wang H, Li R, Xu L, Jiang F, Dong G. CircIMMP2L promotes esophageal squamous cell carcinoma malignant progression via CtBP1 nuclear retention dependent epigenetic modification. Clin Transl Med 2021;11:e519. [PMID: 34586741 DOI: 10.1002/ctm2.519] [Reference Citation Analysis]
38 Zheng K, You ZH, Wang L, Zhou Y, Li LP, Li ZW. MLMDA: a machine learning approach to predict and validate MicroRNA-disease associations by integrating of heterogenous information sources. J Transl Med 2019;17:260. [PMID: 31395072 DOI: 10.1186/s12967-019-2009-x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 10.7] [Reference Citation Analysis]
39 Prasad NR, Karthigeyan M, Vikram K, Parthasarathy R, Reddy KS. Palliative radiotherapy in esophageal cancer. Indian J Surg 2015;77:34-8. [PMID: 25829709 DOI: 10.1007/s12262-013-0817-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
40 Lv XB, Lian GY, Wang HR, Song E, Yao H, Wang MH. Long noncoding RNA HOTAIR is a prognostic marker for esophageal squamous cell carcinoma progression and survival. PLoS One. 2013;8:e63516. [PMID: 23717443 DOI: 10.1371/journal.pone.0063516] [Cited by in Crossref: 115] [Cited by in F6Publishing: 121] [Article Influence: 12.8] [Reference Citation Analysis]
41 Hull R, Mbele M, Makhafola T, Hicks C, Wang SM, Reis RM, Mehrotra R, Mkhize-Kwitshana Z, Hussain S, Kibiki G, Bates DO, Dlamini Z. A multinational review: Oesophageal cancer in low to middle-income countries. Oncol Lett 2020;20:42. [PMID: 32802164 DOI: 10.3892/ol.2020.11902] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Mortensen MB, Fristrup C, Ainsworth A, Nielsen HO, Pless T, Hovendal C. Combined pretherapeutic endoscopic and laparoscopic ultrasonography may predict survival of patients with upper gastrointestinal tract cancer. Surg Endosc. 2011;25:804-812. [PMID: 20676688 DOI: 10.1007/s00464-010-1258-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
43 Nagata S, Aishima S, Fukuzawa K, Takagi H, Yonemasu H, Iwashita Y, Kinoshita T, Wakasugi K. Adenomatoid tumour of the liver. J Clin Pathol. 2008;61:777-780. [PMID: 16843872 DOI: 10.1136/jcp.2007.054684] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
44 Kunisaki C, Makino H, Takagawa R, Yamamoto N, Nagano Y, Fujii S, Kosaka T, Ono HA, Otsuka Y, Akiyama H, Ichikawa Y, Shimada H. Surgical outcomes in esophageal cancer patients with tumor recurrence after curative esophagectomy. J Gastrointest Surg 2008;12:802-10. [PMID: 17952515 DOI: 10.1007/s11605-007-0385-7] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 2.4] [Reference Citation Analysis]
45 Kendall BJ, Rubenstein JH, Cook MB, Vaughan TL, Anderson LA, Murray LJ, Shaheen NJ, Corley DA, Chandar AK, Li L, Greer KB, Chak A, El-Serag HB, Whiteman DC, Thrift AP. Inverse Association Between Gluteofemoral Obesity and Risk of Barrett's Esophagus in a Pooled Analysis. Clin Gastroenterol Hepatol 2016;14:1412-1419.e3. [PMID: 27264393 DOI: 10.1016/j.cgh.2016.05.032] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
46 Ma GW, Situ DR, Ma QL, Long H, Zhang LJ, Lin P, Rong TH. Three-field vs two-field lymph node dissection for esophageal cancer: A meta-analysis. World J Gastroenterol 2014; 20(47): 18022-18030 [PMID: 25548502 DOI: 10.3748/wjg.v20.i47.18022] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 54] [Article Influence: 6.3] [Reference Citation Analysis]
47 Subramanian M, Kozower BD. Immunonutrition in the esophagectomy patient: food for thought. J Thorac Dis 2019;11:2218-21. [PMID: 31372257 DOI: 10.21037/jtd.2019.05.63] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
48 Shang QX, Yang YS, Xu LY, Li EM, Hu WP, Chen LQ. Prognostic significance and role in TNM stage of tumor deposits in esophageal cancer. J Thorac Dis 2017;9:4461-76. [PMID: 29268516 DOI: 10.21037/jtd.2017.10.60] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
49 Tachibana M, Kinugasa S, Shibakita M, Tonomoto Y, Hattori S, Hyakudomi R, Yoshimura H, Dhar DK, Nagasue N. Surgical treatment of superficial esophageal cancer. Langenbecks Arch Surg 2006;391:304-21. [PMID: 16830151 DOI: 10.1007/s00423-006-0063-3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
50 Huang T, Yang J, Liu B, Fu L. A new mouse esophageal cancer cell line (mEC25)-derived pre-clinical syngeneic tumor model for immunotherapy. Cancer Commun (Lond) 2020;40:316-20. [PMID: 32510874 DOI: 10.1002/cac2.12066] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
51 Anderson SE, Minsky BD, Bains M, Hummer A, Kelsen D, Ilson DH. Combined modality chemoradiation in elderly oesophageal cancer patients. Br J Cancer. 2007;96:1823-1827. [PMID: 17533399 DOI: 10.1038/sj.bjc.6603821] [Cited by in Crossref: 43] [Cited by in F6Publishing: 50] [Article Influence: 2.9] [Reference Citation Analysis]
52 Zhao JJ, Li HY, Wang D, Yao H, Sun DW. Abnormal MGMT promoter methylation may contribute to the risk of esophageal cancer: a meta-analysis of cohort studies. Tumour Biol 2014;35:10085-93. [PMID: 25015189 DOI: 10.1007/s13277-014-2276-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
53 Imdahl A, Hentschel M, Kleimaier M, Hopt UT, Brink I. Impact of FDG-PET for staging of oesophageal cancer. Langenbecks Arch Surg 2004;389:283-8. [PMID: 15197549 DOI: 10.1007/s00423-004-0492-9] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
54 Tonouchi H, Mohri Y, Tanaka K, Ohmori Y, Kobayash M, Yokoe T, Kusunoki M. Usefulness of a single trocar for intrathoracic anastomosis during open thoracic surgery for esophageal cancer. Am J Surg 2005;189:240-2. [PMID: 15720999 DOI: 10.1016/j.amjsurg.2004.09.012] [Reference Citation Analysis]
55 Engleman EG. Dendritic cell-based cancer immunotherapy. Semin Oncol. 2003;30:23-29. [PMID: 16843872 DOI: 10.1016/S0093-7754(03)00229-X] [Cited by in Crossref: 57] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
56 Sasagawa H, Shiozaki A, Iitaka D, Ichikawa D, Komatsu S, Fujiwara H, Okamoto K, Nakashima S, Kinoshita O, Murayama Y, Kuriu Y, Ikoma H, Nakanishi M, Ochiai T, Kokuba Y, Otsuji E. Ki-67 labeling index as an independent prognostic factor in human esophageal squamous cell carcinoma. Esophagus 2012;9:195-202. [DOI: 10.1007/s10388-012-0336-6] [Cited by in Crossref: 5] [Article Influence: 0.5] [Reference Citation Analysis]
57 Kgomo M, Mokoena TR, Ker JA. Non-acid gastro-oesophageal reflux is associated with squamous cell carcinoma of the oesophagus. BMJ Open Gastroenterol. 2017;4:e000180. [PMID: 29177066 DOI: 10.1136/bmjgast-2017-000180] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
58 Srisomsap C, Sawangareetrakul P, Subhasitanont P, Panichakul T, Keeratichamroen S, Lirdprapamongkol K, Chokchaichamnankit D, Sirisinha S, Svasti J. Proteomic analysis of cholangiocarcinoma cell line. Proteomics. 2004;4:1135-1144. [PMID: 15048994 DOI: 10.1002/pmic.200300651] [Cited by in Crossref: 52] [Cited by in F6Publishing: 43] [Article Influence: 2.9] [Reference Citation Analysis]
59 Berry MF, Atkins BZ, Tong BC, Harpole DH, D'Amico TA, Onaitis MW. A comprehensive evaluation for aspiration after esophagectomy reduces the incidence of postoperative pneumonia. J Thorac Cardiovasc Surg 2010;140:1266-71. [PMID: 20884018 DOI: 10.1016/j.jtcvs.2010.08.038] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 3.6] [Reference Citation Analysis]
60 Grotenhuis BA, Wijnhoven BP, Hötte GJ, van der Stok EP, Tilanus HW, van Lanschot JJ. Prognostic value of body mass index on short-term and long-term outcome after resection of esophageal cancer. World J Surg 2010;34:2621-7. [PMID: 20596708 DOI: 10.1007/s00268-010-0697-8] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 4.9] [Reference Citation Analysis]
61 Altorki N, Skinner D. Should en bloc esophagectomy be the standard of care for esophageal carcinoma? Ann Surg 2001;234:581-7. [PMID: 11685019 DOI: 10.1097/00000658-200111000-00001] [Cited by in Crossref: 156] [Cited by in F6Publishing: 133] [Article Influence: 7.4] [Reference Citation Analysis]
62 Otterstatter MC, Brierley JD, De P, Ellison LF, Macintyre M, Marrett LD, Semenciw R, Weir HK. Esophageal cancer in Canada: trends according to morphology and anatomical location. Can J Gastroenterol 2012;26:723-7. [PMID: 23061066 DOI: 10.1155/2012/649108] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
63 Jiang Y, Zhang C, Shen W, Li Y, Wang Y, Han J, Liu T, Jia L, Gao F, Liu X, Chen M, Yi G, Dai H, He J. Identification of serum prognostic marker miRNAs and construction of microRNA-mRNA networks of esophageal cancer. PLoS One 2021;16:e0255479. [PMID: 34329340 DOI: 10.1371/journal.pone.0255479] [Reference Citation Analysis]
64 Kaplan T, Gonca C, Han S. Significance of losses of body compositions after oesophagectomy for oesophageal cancer. Eur J Cardiothorac Surg 2021:ezab459. [PMID: 34673941 DOI: 10.1093/ejcts/ezab459] [Reference Citation Analysis]
65 Leong AS, Sormunen RT, Tsui WM, Liew CT. Hep Par 1 and selected antibodies in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma, combined tumours and metastatic carcinoma. Histopathology. 1998;33:318-324. [PMID: 16843872 DOI: 10.1046/j.1365-2559.1998.00522.x] [Cited by in Crossref: 110] [Cited by in F6Publishing: 98] [Article Influence: 6.9] [Reference Citation Analysis]
66 Zhang S, Tan Y, Cai X, Luo K, Wu Z, Lu J. Preoperative weight loss is associated with poorer prognosis in operable esophageal cancer patients: A single-center retrospective analysis of a large cohort of Chinese patients. J Cancer 2020;11:1994-9. [PMID: 32194811 DOI: 10.7150/jca.40344] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Wang CC, Chen X, Yin J, Qu J. An integrated framework for the identification of potential miRNA-disease association based on novel negative samples extraction strategy. RNA Biol 2019;16:257-69. [PMID: 30646823 DOI: 10.1080/15476286.2019.1568820] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
68 Kandaz M, Ertekin MV, Bilici M. Retrospective Analysis of Patients with Esophageal Cancer Treated with Radiotherapy and/or Chemoradiotherapy. Tumori 2012;98:445-50. [DOI: 10.1177/030089161209800408] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
69 Richards HS, Portal A, Absolom K, Blazeby JM, Velikova G, Avery KNL. Patient experiences of an electronic PRO tailored feedback system for symptom management following upper gastrointestinal cancer surgery. Qual Life Res 2021;30:3229-39. [PMID: 32535864 DOI: 10.1007/s11136-020-02539-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
70 Selvasekar CR, Birbeck N, Mcmillan T, Wainwright M, Walker SJ. Photodynamic therapy and the alimentary tract: REVIEW: PHOTODYNAMIC THERAPY. Alimentary Pharmacology & Therapeutics 2001;15:899-915. [DOI: 10.1046/j.1365-2036.2001.00990.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
71 Angeh JE, Huang X, Sattler I, Swan GE, Dahse H, Härtl A, Eloff JN. Antimicrobial and anti-inflammatory activity of four known and one new triterpenoid from Combretum imberbe (Combretaceae). J Ethnopharmacol. 2007;110:56-60. [PMID: 16843872 DOI: 10.1016/j.jep.2006.09.002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
72 Luo Y, Chen C. The roles and regulation of the KLF5 transcription factor in cancers. Cancer Sci 2021;112:2097-117. [PMID: 33811715 DOI: 10.1111/cas.14910] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
73 Zhao Q, Hu F, Xiao Z, Li M, Wu X, Zhao Y, Wu Y, Yin J, Lin L, Zhang H, Zhang L, Cho CH, Shen J. Comprehensive molecular profiling of the B7 family in gastrointestinal cancer. Cell Prolif 2018;51:e12468. [PMID: 29999557 DOI: 10.1111/cpr.12468] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
74 Silvers MA, Savva J, Huggins CE, Truby H, Haines T. Potential benefits of early nutritional intervention in adults with upper gastrointestinal cancer: a pilot randomised trial. Support Care Cancer 2014;22:3035-44. [PMID: 24908429 DOI: 10.1007/s00520-014-2311-3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
75 Buskens CJ, Marsman WA, Wesseling JG, Offerhaus GJ, Yamamoto M, Curiel DT, Bosma PJ, van Lanschot JJ. A genetically retargeted adenoviral vector enhances viral transduction in esophageal carcinoma cell lines and primary cultured esophageal resection specimens. Ann Surg 2003;238:815-24; discussion 825-6. [PMID: 14631218 DOI: 10.1097/01.sla.0000098622.47909.c0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
76 Napier KJ, Scheerer M, Misra S. Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities. World J Gastrointest Oncol 2014; 6(5): 112-120 [PMID: 24834141 DOI: 10.4251/wjgo.v6.i5.112] [Cited by in CrossRef: 373] [Cited by in F6Publishing: 355] [Article Influence: 46.6] [Reference Citation Analysis]
77 Zhong B, Wang T, Lun X, Zhang J, Zheng S, Yang W, Li W, Xiang AP, Chen Z. Contribution of nestin positive esophageal squamous cancer cells on malignant proliferation, apoptosis, and poor prognosis. Cancer Cell Int 2014;14:57. [PMID: 24966803 DOI: 10.1186/1475-2867-14-57] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
78 Chasen MR, Bhargava R. A rehabilitation program for patients with gastroesophageal cancer--a pilot study. Support Care Cancer. 2010;18 Suppl 2:S35-S40. [PMID: 20177712 DOI: 10.1007/s00520-010-0828-7] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
79 Fan KH, Chao YK, Chang JT, Tsang NM, Liao CT, Chang KP, Lin CY, Wang HM, Hsu CL, Huang SF. A retrospective analysis of the treatment results for advanced synchronous head and neck and esophageal cancer. BJR Open 2019;1:20190015. [PMID: 33178944 DOI: 10.1259/bjro.20190015] [Reference Citation Analysis]
80 Alghamedi A, Buduhan G, Tan L, Srinathan SK, Sulman J, Darling G, Kidane B. Quality of life assessment in esophagectomy patients. Ann Transl Med 2018;6:84. [PMID: 29666807 DOI: 10.21037/atm.2017.11.38] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
81 Shang QX, Chen LQ, Hu WP, Deng HY, Yuan Y, Cai J. Three-field lymph node dissection in treating the esophageal cancer. J Thorac Dis 2016;8:E1136-49. [PMID: 27867579 DOI: 10.21037/jtd.2016.10.20] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
82 Fujimiya M, Inui A. Peptidergic regulation of gastrointestinal motility in rodents. Peptides. 2000;21:1565-1582. [PMID: 16843872 DOI: 10.1016/S0196-9781(00)00313-2] [Cited by in Crossref: 72] [Cited by in F6Publishing: 26] [Article Influence: 4.5] [Reference Citation Analysis]
83 Navaneethan U, Eubanks S. Approach to patients with esophageal Dysphagia. Surg Clin North Am 2015;95:483-9. [PMID: 25965125 DOI: 10.1016/j.suc.2015.02.004] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
84 Molendijk J, Nguyen TM, Brown I, Mohamed A, Lim Y, Barclay J, Hodson MP, Hennessy TP, Krause L, Morrison M, Hill MM. Chronic High-Fat Diet Induces Early Barrett's Esophagus in Mice through Lipidome Remodeling. Biomolecules 2020;10:E776. [PMID: 32429496 DOI: 10.3390/biom10050776] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
85 Singh B, Sahu PM, Lohiya RK, Sharma MK, Singh HL, Singh S. Anti-inflammatory activity of alkanoids and triterpenoids from Trichodesma amplexicaule Roth. Phytomedicine. 2006;13:152-156. [PMID: 16843872 DOI: 10.1016/j.phymed.2004.06.018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
86 Ohmori S, Shiraki K, Sugimoto K, Sakai T, Fujikawa K, Wagayama H, Takase K, Nakano T. High expression of CD34- positive sinusoidal endothelial cells is a risk factor for hepatocellular carcinoma in patients with HCV-associated chronic liver diseases. Hum Pathol. 2001;32:1363-1370. [PMID: 16843872 DOI: 10.1053/hupa.2001.29678] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
87 Takeda H, Yamakawa M, Takahashi T, Imai Y, Ishikawa M. An immunohistochemical study with an estrogen receptor- related protein (ER-D5) in human colorectal cancer. Cancer. 1992;69:907-912. [PMID: 16843872 DOI: 10.1002/1097-0142(19920215)69:4%3C907::AID-CNCR2820690412%3E3.0.CO;2-L] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
88 Gockel I, Exner C, Junginger T. Morbidity and mortality after esophagectomy for esophageal carcinoma: a risk analysis. World J Surg Oncol 2005;3:37. [PMID: 15969746 DOI: 10.1186/1477-7819-3-37] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 2.4] [Reference Citation Analysis]
89 Meng MB, Jiang C, Tian LJ, Liu CL, Zhuang HQ, Chen ZJ, Song YC, Wang J, Pang QS, Zhao LJ, Yuan ZY, Wang P. Late course accelerated hyperfractionation radiotherapy for locally advanced esophageal squamous cell carcinoma. Thorac Cancer 2013;4:174-85. [PMID: 28920199 DOI: 10.1111/j.1759-7714.2012.00166.x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
90 Shai SE, Lin YH, Lai YL, Tang HW, Hsieh YW, Hung SC. Phantom simulation of liver metastasis on a positron emission tomography with computed tomography scan after neoadjuvant chemoradiotherapy for distal esophageal cancer: a case report. J Med Case Rep 2020;14:106. [PMID: 32631396 DOI: 10.1186/s13256-020-02391-z] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
91 Gagliardi G, Bayar S, Smith R, Salem RR. Preoperative staging of rectal cancer using magnetic resonance imaging with external phase-arrayed coils. Arch Surg. 2002;137:447-451. [PMID: 16843872 DOI: 10.1001/archsurg.137.4.447] [Cited by in Crossref: 82] [Cited by in F6Publishing: 72] [Article Influence: 5.1] [Reference Citation Analysis]
92 Grant MJ, Didier RA, Stevens JS, Beyder DD, Hunter JG, Thomas CR, Coakley FV. Radiation-induced liver disease as a mimic of liver metastases at serial PET/CT during neoadjuvant chemoradiation of distal esophageal cancer. Abdom Imaging 2014;39:963-8. [PMID: 24668312 DOI: 10.1007/s00261-014-0125-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
93 Hu W, Liu J, He F, Wang C, Ma Z. Supraclavicular node metastasis in thoracic esophageal squamous cell carcinoma. Eur Surg 2014;46:139-43. [DOI: 10.1007/s10353-014-0272-x] [Reference Citation Analysis]
94 Wang J, Wei C, Tucker SL, Myles B, Palmer M, Hofstetter WL, Swisher SG, Ajani JA, Cox JD, Komaki R, Liao Z, Lin SH. Predictors of Postoperative Complications After Trimodality Therapy for Esophageal Cancer. International Journal of Radiation Oncology*Biology*Physics 2013;86:885-91. [DOI: 10.1016/j.ijrobp.2013.04.006] [Cited by in Crossref: 72] [Cited by in F6Publishing: 68] [Article Influence: 8.0] [Reference Citation Analysis]
95 Tantai JC, Zhang Y, Zhao H. Heterophyllin B inhibits the adhesion and invasion of ECA-109 human esophageal carcinoma cells by targeting PI3K/AKT/β-catenin signaling. Mol Med Rep 2016;13:1097-104. [PMID: 26647768 DOI: 10.3892/mmr.2015.4659] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
96 Zhang LQ, Du XJ, Zhou FY, Chen PN, Wang HL, Sun L, Li XL. Awareness for Endoscopic Screening Among Accompanying Children of Hospitalized Esophageal Cancer Patients in Henan. J Cancer Educ 2020. [PMID: 33137207 DOI: 10.1007/s13187-020-01911-1] [Reference Citation Analysis]
97 Cao X, Zhang L, Feng GR, Yang J, Wang RY, Li J, Zheng XM, Han YJ. Preoperative Cyfra21-1 and SCC-Ag serum titers predict survival in patients with stage II esophageal squamous cell carcinoma. J Transl Med. 2012;10:197. [PMID: 22999061 DOI: 10.1186/1479-5876-10-197] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
98 Kito Y, Suzuki H. Electrophysiological properties of gastric pacemaker potentials. J Smooth Muscle Res. 2003;39:163-173. [PMID: 16843872 DOI: 10.1540/jsmr.39.163] [Cited by in Crossref: 26] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
99 Hünerbein M, Stroszczynski C, Moesta KT, Schlag PM. Treatment of thoracic anastomotic leaks after esophagectomy with self-expanding plastic stents. Ann Surg. 2004;240:801-807. [PMID: 15492561 DOI: 10.1097/01.sla.0000143122.76666.ae] [Cited by in Crossref: 151] [Cited by in F6Publishing: 115] [Article Influence: 8.4] [Reference Citation Analysis]
100 Pickens A. Racial Disparities in Esophageal Cancer. Thorac Surg Clin 2022;32:57-65. [PMID: 34801196 DOI: 10.1016/j.thorsurg.2021.09.004] [Reference Citation Analysis]
101 Shen S, Araujo JL, Altorki NK, Sonett JR, Rodriguez A, Sungur-Stasik K, Spinelli CF, Neugut AI, Abrams JA. Variation by stage in the effects of prediagnosis weight loss on mortality in a prospective cohort of esophageal cancer patients. Dis Esophagus 2017;30:1-7. [PMID: 28859366 DOI: 10.1093/dote/dox073] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
102 Sutcliffe R, Maguire D, Murphy P, Portmann B, Rela M, O'Sullivan G, Mufti G, Heaton N. Detection and clinical significance of bone marrow micrometastases in patients undergoing liver transplantation for hepatocellular carcinoma. Transplantation. 2005;80:88-94. [PMID: 16843872 DOI: 10.1097/01.TP.0000164499.40952.C8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
103 Xie Z, Chen G, Zhang X, Li D, Huang J, Yang C, Zhang P, Qin Y, Duan Y, Gong B, Li Z. Salivary microRNAs as promising biomarkers for detection of esophageal cancer. PLoS One 2013;8:e57502. [PMID: 23560033 DOI: 10.1371/journal.pone.0057502] [Cited by in Crossref: 90] [Cited by in F6Publishing: 83] [Article Influence: 10.0] [Reference Citation Analysis]
104 Hellstadius Y, Malmström M, Lagergren P, Sundbom M, Wikman A. Reflecting a crisis reaction: Narratives from patients with oesophageal cancer about the first 6 months after diagnosis and surgery. Nurs Open 2019;6:1471-80. [PMID: 31660175 DOI: 10.1002/nop2.348] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
105 Liu Q, Li W, Yang S, Liu Z. High expression of uPA related to p38MAPK in esophageal cancer indicates poor prognosis. Onco Targets Ther 2018;11:8427-34. [PMID: 30568465 DOI: 10.2147/OTT.S181701] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
106 Terada T, Ohta T, Nakanuma Y. Expression of oncogene products, anti-oncogene products and oncofetal antigens in intraductal papillary-mucinous neoplasm of the pancreas. Histopathology. 1996;29:355-361. [PMID: 16843872 DOI: 10.1111/j.1365-2559.1996.tb01419.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
107 Delvaux V, Sciot R, Neuville B, Moerman P, Peeters M, Filez L, Van Beckevoort D, Ectors N, Geboes K. Multifocal epithelioid angiosarcoma of the small intestine. Virchows Arch. 2000;437:90-94. [PMID: 10963385 DOI: 10.1007/s004280000183] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.2] [Reference Citation Analysis]
108 Smith JA, Bhathal PS, Cuthbertson AM. Angiosarcoma of the colon. Report of a case with long-term survival. Dis Colon Rectum. 1990;33:330-333. [PMID: 16843872 DOI: 10.1007/BF02055479] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
109 Lopes AB, Fagundes RB. Esophageal squamous cell carcinoma - precursor lesions and early diagnosis. World J Gastrointest Endosc 2012; 4(1): 9-16 [PMID: 22267978 DOI: 10.4253/wjge.v4.i1.9] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
110 Shen FF, Zhou FY, Xue QS, Pan Y, Zheng L, Zhang H, Wang LD, Zheng HF. Association between CYP1A1 polymorphisms and esophageal cancer: a meta-analysis. Mol Biol Rep. 2013;40:6035-6042. [PMID: 24065535 DOI: 10.1007/s11033-013-2713-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
111 Sakanaka K, Fujii K, Mizowaki T. Adaptive radiotherapy in locally advanced esophageal cancer with atelectasis: a case report. BMC Cancer 2020;20:21. [PMID: 31906910 DOI: 10.1186/s12885-019-6505-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
112 Kumar S, Kumar R, Gogia A, Arava S, Tripathi M. Esophageal Metastases from Breast Carcinoma: a Rare Delayed Metastases After 15 Years. J Gastrointest Cancer 2019;50:674-7. [PMID: 29717415 DOI: 10.1007/s12029-018-0109-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
113 Allison KH, Yoder BJ, Bronner MP, Goldblum JR, Rubin BP. Angiosarcoma involving the gastrointestinal tract: a series of primary and metastatic cases. Am J Surg Pathol. 2004;28:298-307. [PMID: 15104292 DOI: 10.1097/00000478-200403000-00002] [Cited by in Crossref: 67] [Cited by in F6Publishing: 62] [Article Influence: 3.7] [Reference Citation Analysis]
114 Persson J, Smedh U, Johnsson Å, Ohlin B, Sundbom M, Nilsson M, Lundell L, Sund B, Johnsson E. Fully covered stents are similar to semi-covered stents with regard to migration in palliative treatment of malignant strictures of the esophagus and gastric cardia: results of a randomized controlled trial. Surg Endosc 2017;31:4025-33. [PMID: 28236016 DOI: 10.1007/s00464-017-5441-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
115 Borecký J, Maia IG, Arruda P. Mitochondrial uncoupling proteins in mammals and plants. Biosci Rep. 2001;21:201-212. [PMID: 16843872 DOI: 10.1023/A:1013604526175] [Cited by in Crossref: 45] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
116 Soletti RC, Biasoli D, Rodrigues NALV, Delou JMA, Maciel R, Chagas VLA, Martins RAP, Rehen SK, Borges HL. Inhibition of pRB Pathway Differentially Modulates Apoptosis in Esophageal Cancer Cells. Transl Oncol 2017;10:726-33. [PMID: 28734226 DOI: 10.1016/j.tranon.2017.06.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
117 Ip JC, Ko JM, Yu VZ, Chan KW, Lam AK, Law S, Tong DK, Lung ML. A versatile orthotopic nude mouse model for study of esophageal squamous cell carcinoma. Biomed Res Int 2015;2015:910715. [PMID: 25834829 DOI: 10.1155/2015/910715] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
118 Sharma R, Rajasekar MR, Raghuvanshi A. Immunosuppresion strategies after liver transplantation: a single centre experience in 57 liver transplan recipients. Indian J Surg. 2007;69:187-190. [PMID: 16843872 DOI: 10.1007/s12262-007-0018-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
119 Brown CJ, Falck VG, MacLean A. Angiosarcoma of the colon and rectum: report of a case and review of the literature. DisColon Rectum. 2004;47:2202-2207. [PMID: 16843872 DOI: 10.1007/s10350-004-0698-5] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
120 Schandl A, Johar A, Lagergren J, Lagergren P. Lymphadenectomy and health-related quality of life after oesophageal cancer surgery: a nationwide, population-based cohort study. BMJ Open 2016;6:e012624. [PMID: 27566643 DOI: 10.1136/bmjopen-2016-012624] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
121 Ng W, Jacob S, Delaney G, Do V, Barton M. Estimation of an optimal chemotherapy utilisation rate for upper gastrointestinal cancers: setting an evidence-based benchmark for the best-quality cancer care. Gastroenterol Res Pract 2015;2015:753480. [PMID: 25883645 DOI: 10.1155/2015/753480] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
122 Murphy PM, Modi P, Rahamim J, Wheatley T, Lewis SJ. An investigation into the current peri-operative nutritional management of oesophageal carcinoma patients in major carcinoma centres in England. Ann R Coll Surg Engl 2006;88:358-62. [PMID: 16834854 DOI: 10.1308/003588406X106522] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
123 Berry MF. Esophageal cancer: staging system and guidelines for staging and treatment. J Thorac Dis. 2014;6 Suppl 3:S289-S297. [PMID: 24876933 DOI: 10.3978/j.issn.2072-1439.2014.03.11] [Cited by in F6Publishing: 57] [Reference Citation Analysis]
124 Reim D, Friess H. Feeding Challenges in Patients with Esophageal and Gastroesophageal Cancers. Gastrointest Tumors 2016;2:166-77. [PMID: 27403411 DOI: 10.1159/000442907] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
125 Zhang J, Jiang Y, Wu C, Cai S, Wang R, Zhen Y, Chen S, Zhao K, Huang Y, Luketich J, Chen H. Comparison of clinicopathologic features and survival between eastern and western population with esophageal squamous cell carcinoma. J Thorac Dis 2015;7:1780-6. [PMID: 26623101 DOI: 10.3978/j.issn.2072-1439.2015.10.39] [Cited by in F6Publishing: 16] [Reference Citation Analysis]
126 Tachimori Y. Role of salvage esophagectomy after definitive chemoradiotherapy. Gen Thorac Cardiovasc Surg 2009;57:71-8. [PMID: 19214447 DOI: 10.1007/s11748-008-0337-5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
127 Maweni RM, Manikavasagar V, Sunderland N, Chaudhry S. Thoracic oesophageal cancer as a cause of stridor: a literature review. BMJ Case Rep 2018;2018:bcr-2018-224872. [PMID: 29844036 DOI: 10.1136/bcr-2018-224872] [Reference Citation Analysis]
128 Chen X, Wang CC, Yin J, You ZH. Novel Human miRNA-Disease Association Inference Based on Random Forest. Mol Ther Nucleic Acids 2018;13:568-79. [PMID: 30439645 DOI: 10.1016/j.omtn.2018.10.005] [Cited by in Crossref: 49] [Cited by in F6Publishing: 37] [Article Influence: 12.3] [Reference Citation Analysis]
129 Ren K, Li Y, Lu H, Li Z, Li Z, Wu K, Li Z, Han X. Long Noncoding RNA HOTAIR Controls Cell Cycle by Functioning as a Competing Endogenous RNA in Esophageal Squamous Cell Carcinoma. Transl Oncol 2016;9:489-97. [PMID: 27816685 DOI: 10.1016/j.tranon.2016.09.005] [Cited by in Crossref: 51] [Cited by in F6Publishing: 55] [Article Influence: 8.5] [Reference Citation Analysis]
130 Cheng C, Ho RTH, Guo Y, Zhu M, Yang W, Li Y, Liu Z, Zhuo S, Liang Q, Chen Z, Zeng Y, Yang J, Zhang Z, Zhang X, Monroe-Wise A, Yeung SC. Development and Feasibility of a Mobile Health-Supported Comprehensive Intervention Model (CIMmH) for Improving the Quality of Life of Patients With Esophageal Cancer After Esophagectomy: Prospective, Single-Arm, Nonrandomized Pilot Study. J Med Internet Res 2020;22:e18946. [PMID: 32808933 DOI: 10.2196/18946] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
131 Israel DA, Peek RM Jr. The role of persistence in Helicobacter pylori pathogenesis. Curr Opin Gastroenterol. 2006;22:3-7. [PMID: 16843872 DOI: 10.1097/01.mog.0000194790.51714.f0] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
132 Bevilacqua S, Gallo M, Franco R, Rossi A, De Luca A, Rocco G, Botti G, Gridelli C, Normanno N. A "live" biopsy in a small-cell lung cancer patient by detection of circulating tumor cells. Lung Cancer. 2009;65:123-125. [PMID: 16843872 DOI: 10.1634/10.1016/j.lungcan.2009.01.019] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
133 Ji W, Zheng W, Li B, Cao C, Mao W. Influence of body mass index on the long-term outcomes of patients with esophageal squamous cell carcinoma who underwent esophagectomy as a primary treatment: A 10-year medical experience. Medicine (Baltimore) 2016;95:e4204. [PMID: 27442643 DOI: 10.1097/MD.0000000000004204] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 2.2] [Reference Citation Analysis]
134 Huang S, Li Y, Ma H, Wang W, Zheng S, Ke Y, Li F. Investigating the Survival Benefit of Combining Radiotherapy for Surgery Treated Locally Advanced Esophageal Squamous Cell Carcinoma Patients Aged 65 and Older. J Gastrointest Surg 2019;23:2111-8. [PMID: 30895428 DOI: 10.1007/s11605-019-04200-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
135 Siewert JR, Stein HJ, Feith M, Bruecher BL, Bartels H, Fink U. Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg. 2001;234:360-7; discussion 368. [PMID: 11524589 DOI: 10.1097/00000658-200109000-00010] [Cited by in Crossref: 367] [Cited by in F6Publishing: 320] [Article Influence: 17.5] [Reference Citation Analysis]
136 Ryan AM, Hearty A, Prichard RS, Cunningham A, Rowley SP, Reynolds JV. Association of hypoalbuminemia on the first postoperative day and complications following esophagectomy. J Gastrointest Surg. 2007;11:1355-1360. [PMID: 17682826 DOI: 10.1007/s11605-007-0223-y] [Cited by in Crossref: 80] [Cited by in F6Publishing: 71] [Article Influence: 5.3] [Reference Citation Analysis]
137 Li L, Zhao L, Lin B, Su H, Su M, Xie D, Jin X, Xie C. Adjuvant Therapeutic Modalities Following Three-field Lymph Node Dissection for Stage II/III Esophageal Squamous Cell Carcinoma. J Cancer 2017;8:2051-9. [PMID: 28819406 DOI: 10.7150/jca.18981] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
138 Zoli M, Magalotti D, Giampaolo B, Gino G, Orlandini C, Grimaldi M, Marchesini G, Pisi E. Functional hepatic flow and Doppler-assessed total hepatic flow in control subjects and in patients with cirrhosis. Journal of Hepatology 1995;23:129-34. [DOI: 10.1016/0168-8278(95)80326-2] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 1.8] [Reference Citation Analysis]
139 Kim SG. What Is the Next Step after Endoscopic Resection of Superficial Esophageal Squamous Cell Carcinoma? Gut Liver 2015;9:693-4. [PMID: 26503566 DOI: 10.5009/gnl15109] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
140 Li X, Guo S, Min L, Guo Q, Zhang S. miR-92a-3p promotes the proliferation, migration and invasion of esophageal squamous cell cancer by regulating PTEN. Int J Mol Med 2019;44:973-81. [PMID: 31257524 DOI: 10.3892/ijmm.2019.4258] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
141 Shang QX, Yang YS, Hu WP, Yuan Y, Ji AF, Chen LQ. Prognostic significance and role of thoracic lymph node metastasis based on Chinese expert consensus in esophageal cancer. Ann Transl Med 2019;7:381. [PMID: 31555695 DOI: 10.21037/atm.2019.07.63] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
142 Tétreault MP. Esophageal Cancer: Insights From Mouse Models. Cancer Growth Metastasis 2015;8:37-46. [PMID: 26380556 DOI: 10.4137/CGM.S21218] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
143 Schandl A, Kauppila JH, Anandavadivelan P, Johar A, Lagergren P. Predicting the Risk of Weight Loss After Esophageal Cancer Surgery. Ann Surg Oncol 2019;26:2385-91. [PMID: 31004297 DOI: 10.1245/s10434-019-07352-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
144 Yun T, Liu Y, Gao D, Linghu E, Brock MV, Yin D, Zhan Q, Herman JG, Guo M. Methylation of CHFR sensitizes esophageal squamous cell cancer to docetaxel and paclitaxel. Genes Cancer 2015;6:38-48. [PMID: 25821560 DOI: 10.18632/genesandcancer.46] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
145 Zhang M, Zhang C, Wu QC. Health-related quality of life and survival among 10-year survivors of esophageal cancer surgery: gastric tube reconstruction versus whole stomach reconstruction. J Thorac Dis 2019;11:3284-91. [PMID: 31559031 DOI: 10.21037/jtd.2019.08.56] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
146 Wang DB, Sun ZY, Deng LM, Zhu DQ, Xia HG, Zhu PZ. Neoadjuvant Chemoradiotherapy Improving Survival Outcomes for Esophageal Carcinoma: An Updated Meta-analysis. Chin Med J (Engl) 2016;129:2974-82. [PMID: 27958230 DOI: 10.4103/0366-6999.195464] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
147 Omoto I, Matsumoto M, Okumura H, Uchikado Y, Setoyama T, Kita Y, Owaki T, Kijima Y, Shinchi H, Ishigami S, Ueno S, Natsugoe S. Expression of vascular endothelial growth factor-C and vascular endothelial growth factor receptor-3 in esophageal squamous cell carcinoma. Oncol Lett 2014;7:1027-32. [PMID: 24944663 DOI: 10.3892/ol.2014.1823] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
148 Lv XB, Lian GY, Wang HR, Song E, Yao H, Wang MH. Long noncoding RNA HOTAIR is a prognostic marker for esophageal squamous cell carcinoma progression and survival. PLoS One. 2013;8:e63516. [PMID: 23717443 DOI: 10.1371/journal.pone.] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
149 Niu YW, Wang GH, Yan GY, Chen X. Integrating random walk and binary regression to identify novel miRNA-disease association. BMC Bioinformatics 2019;20:59. [PMID: 30691413 DOI: 10.1186/s12859-019-2640-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
150 Ding Y, Ma Q, Liu F, Zhao L, Wei W. The Potential Use of Salivary miRNAs as Promising Biomarkers for Detection of Cancer: A Meta-Analysis. PLoS One 2016;11:e0166303. [PMID: 27832115 DOI: 10.1371/journal.pone.0166303] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
151 Järvinen T, Ilonen I, Kauppi J, Volmonen K, Salo J, Räsänen J. Low skeletal muscle mass in stented esophageal cancer predicts poor survival: A retrospective observational study. Thorac Cancer 2018;9:1429-36. [PMID: 30156376 DOI: 10.1111/1759-7714.12855] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
152 Thakur B, Zhang CS, Guo Y, Lama R. Comparison Between Concurrent Chemoradiation Followed by Surgery vs. Surgery for Locally Advanced Cancer of Esophagus. Indian J Surg 2011;73:111-5. [PMID: 22468059 DOI: 10.1007/s12262-010-0182-5] [Reference Citation Analysis]
153 Law S, Wong KH, Kwok KF, Chu KM, Wong J. Predictive factors for postoperative pulmonary complications and mortality after esophagectomy for cancer. Ann Surg. 2004;240:791-800. [PMID: 15492560 DOI: 10.1097/01.sla.0000143123.24556.1c] [Cited by in Crossref: 273] [Cited by in F6Publishing: 242] [Article Influence: 15.2] [Reference Citation Analysis]
154 Huang S, Zheng S, Gong T, Ma H, Ke Y, Zhao S, Wang W, Jia L, Zhang X. Survival benefit evaluation of radiotherapy in esophageal cancer patients aged 80 and older. Oncotarget 2017;8:112094-102. [PMID: 29340114 DOI: 10.18632/oncotarget.22884] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
155 Zhao Y, Chen X, Yin J. A Novel Computational Method for the Identification of Potential miRNA-Disease Association Based on Symmetric Non-negative Matrix Factorization and Kronecker Regularized Least Square. Front Genet 2018;9:324. [PMID: 30186308 DOI: 10.3389/fgene.2018.00324] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
156 Garces CA, McAuliffe PF, Hochwald SN, Cance WG. Neoadjuvant therapy in the treatment of solid tumors. Curr Probl Surg 2006;43:457-551. [PMID: 16860653 DOI: 10.1067/j.cpsurg.2006.04.003] [Reference Citation Analysis]
157 Kendall BJ, Macdonald GA, Hayward NK, Prins JB, O’Brien S, Whiteman DC. The risk of Barrett’s esophagus associated with abdominal obesity in males and females. Int J Cancer. 2013;132:2192-2199. [PMID: 23034724 DOI: 10.1002/ijc.27887] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
158 Hanna L, Huggins CE, Furness K, Silvers MA, Savva J, Frawley H, Croagh D, Cashin P, Low L, Bauer J, Truby H, Haines T. Effect of early and intensive nutrition care, delivered via telephone or mobile application, on quality of life in people with upper gastrointestinal cancer: study protocol of a randomised controlled trial. BMC Cancer 2018;18:707. [PMID: 29970033 DOI: 10.1186/s12885-018-4595-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
159 Baker M, Halliday V, Williams RN, Bowrey DJ. A systematic review of the nutritional consequences of esophagectomy. Clin Nutr. 2016;35:987-994. [PMID: 26411750 DOI: 10.1016/j.clnu.2015.08.010] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 6.6] [Reference Citation Analysis]
160 Reynolds JV, Muldoon C, Hollywood D, Ravi N, Rowley S, O'Byrne K, Kennedy J, Murphy TJ. Long-term outcomes following neoadjuvant chemoradiotherapy for esophageal cancer. Ann Surg 2007;245:707-16. [PMID: 17457163 DOI: 10.1097/01.sla.0000254367.15810.38] [Cited by in Crossref: 118] [Cited by in F6Publishing: 107] [Article Influence: 7.9] [Reference Citation Analysis]
161 Abraham JA, Hornicek FJ, Kaufman AM, Harmon DC, Springfield DS, Raskin KA, Mankin HJ, Kirsch DG, Rosenberg AE, Nielsen GP. Treatment and outcome of 82 patients with angiosarcoma. Ann Surg Oncol. 2007;14:1953-1967. [PMID: 17356953 DOI: 10.1245/s10434-006-9335-y] [Cited by in Crossref: 192] [Cited by in F6Publishing: 154] [Article Influence: 12.8] [Reference Citation Analysis]
162 Shen FF, Yue WB, Zhou FY, Pan Y, Zhao XK, Jin Y, Song X, Li B, Han XN, Tang S, Li Y, Yuan G, Chen LS, Liu YL, Hu YL, Li XM, Ren JL, Wang LD. Variations in the MHC region confer risk to esophageal squamous cell carcinoma on the subjects from high-incidence area in northern China. PLoS One 2014;9:e90438. [PMID: 24595008 DOI: 10.1371/journal.pone.0090438] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
163 Zimmerman RL, Burke MA, Young NA, Solomides CC, Bibbo M. Diagnostic value of hepatocyte paraffin 1 antibody to discriminate hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsies of the liver. Cancer 2001;93:288-91. [DOI: 10.1002/cncr.9043] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 2.3] [Reference Citation Analysis]